An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cytotherapy Année : 2022

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry

Domaines

Cancer

Dates et versions

hal-03790665 , version 1 (28-09-2022)

Identifiants

Citer

Daniel J Weiss, Anthony Filiano, Jacques Galipeau, Maroun Khoury, Mauro Krampera, et al.. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry. Cytotherapy, 2022, 24 (11), pp.1071-1073. ⟨10.1016/j.jcyt.2022.07.010⟩. ⟨hal-03790665⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More